WE HEREBY PUBLISH OUR BIOCEUTICAL PATENT PORTFOLIO THAT MAY PROVIDE EFFICIENT CURATIVE & PREVENTIVE MEANS FOR THE MOST SEEN MEDICAL AILMENTS IN LUXEMBOURG. OUR FORMULATIONS PORTFOLIO LISTED IN THIS DATASET INCLUDES BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS, TNF-A & NF-KAPPA B COX-2 INTERLEUKIN-6 SUPPRESSIVE AND IMMUNOMODULATIVE AGENTS FOR AUTOIMMUNE DISEASES, FMO3 SUPPRESSIVE ANALGESIC AGENTS, THYROGENIC & THYROMODULATORY AGENTS, RNA POLYMERASE & DNA POLYMERASE & VIRAL DNA GYRASE SUPPRESSIVE ANTIVIRAL AGENTS, TOPOISOMERASE I & II, RIBONUCLEOTIDE REDUCTASE SUPPRESSIVE ANTIBACTERIAL AGENTS, GLUT4 TRANSLOCATIVE ANTIDIABETIC AGENTS AND MANY OTHER INNOVATIVE FORMULATIONS WITH NOVEL MECHANISMS OF ACTION.

WE HEREBY DISCLOSE OUR INVENTIONS FOR THE GREAT PEOPLE OF LUXEMBOURG IN ORDER TO PROVIDE AND EFFICIENT CONTRIBUTION TO THEIR COLLECTIVE HEALTH, AND FOR ALL.

BEST REGARDS

ERDAL CAN ALKOCLAR & METEHAN YESIL

Resources

TR201305730 WIPO NOVELTY REPORT

A COMPOSITION PROMOTING HEPATIC AND INTESTINAL TISSUE RENEWAL

The invention relates to a composition promoting hepatic and intestinal tissue renewal.

A COMPOSITION FOR PROMOTING TISSUE RENEWAL

The invention relates to a composition formed for promoting the tissue renewal.

TR201305306 WIPO NOVELTY REPORT

TR201305054 WIPO PATENT NOVELTY REPORT

TR201304493 WIPO NOVELTY REPORT

TR201304603 WIPO PATENT NOVELTY REPORT

A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-CANCER CHARACTER BY SUPPRESSING THE BCL-2 EXPRESSION

The invention relates to a composition formed for suppressing the Bcl-2 expression and for exhibiting the anti-cancer character.

A COMPOSITION COMPRISING PICRORETINE DERIVATIVES THAT EXHIBIT THE HYPOLIPIDEMIC CHARACTER AND THE USE OF THIS COMPOSITION FOR THE TREATMENT OF HIGH CHOLESTEROL

The invention relates to a composition formed for exhibiting hypolipidemic character

A COMPOSITION COMPRISING SYNTHETIC PROTOBIOSIDE DERIVATIVES THAT EXHIBIT THE HYPOLIPIDEMIC CHARACTER

The invention relates to a composition formed for exhibiting hypolipidemic character

A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT THE HYPOLIPIDEMIC CHARACTER

The invention relates to a composition comprising synthetic components formed for exhibiting hypolipidemic character.

A COMPOSITION COMPRISING ANTI-BACTERIAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING dnaB HELICASE

The invention relates to a composition formed for suppressing dnaB helicase.

A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING HIF PROLYL HYDROXYLASE AND THE USE OF THIS COMPOSITION AS AN ADJUVANT CANCER THERAPY

The invention relates to a composition formed for suppressing HIF prolyl hydroxylase and for use as an adjuvant cancer therapy

AN ANTIVIRAL COMPOSITION

The invention relates to a composition formed for the purpose of antiviral use

A NEUROTROPHIC COMPOSITION

The invention relates to a neurotrophic composition

A COMPOSITION COMPRISING LIPOLYTIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING MONOCYTE CHEMOATTRACTANT PROTEIN-1

The invention relates to a composition comprising lipolytic components formed for suppressing monocyte chemoattractant protein-1

A COMPOSITION COMPRISING ANTI-CARCINOGENIC GIPENOLIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING PI3-KINASE ALPHA

The invention relates to a composition comprising anti-carcinogenic gipenolin derivatives formed for suppressing PI3-kinase alpha

A COMPOSITION COMPRISING ANTI-CARCINOGENIC GIPENOLIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING ERK

The invention relates to a composition comprising anti-carcinogenic gipenolin derivatives formed for suppressing ERK

A COMPOSITION COMPRISING ANTI-CARCINOGENIC GIPENOLIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING ERK

The invention relates to a composition comprising anti-carcinogenic gipenolin derivatives formed for suppressing ERK.

A COMPOSITION COMPRISING SORININ DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING H3K27 METHYLATION

The invention relates to a composition comprising sorinin derivatives formed for suppressing H3K27 methylation.

A COMPOSITION COMPRISING ANTI-CARCINOGENIC PROTOSPINOL DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING HYPOXIA-INDUCIBLE FACTOR (HIF) 1-ALPHA

The invention relates to a composition comprising anti-carcinogenic protospinol derivatives formed for suppressing hypoxia-inducible factor (HIF) 1-alpha.

A COMPOSITION COMPRISING ANABOLIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF PROMOTING THE AGRIN EXPRESSION

The invention relates to a composition comprising the anabolic components formed for promoting the agrin expression.

A COMPOSITION COMPRISING TRICYCLOPENTAONE DERIVATIVES THAT SUPPORT THE INCREASE OF THE MUSCLE STRENGTH BY MEANS OF AN INCREASE IN THE SENSITIVITY OF MUSCLE-SPECIFIC KINASE RECEPTOR

The invention relates to a composition comprising tricyclopentaone derivatives that support the increase of the muscular strength formed for increasing the sensitivity of the…

A COMPOSITION CONTAINING PICRORETOSIDE DERIVATIVES THAT EXHIBIT PRO-DOPAMINERGIC CHARACTER FOR INCREASING THE SENSITIVITY OF DOPAMINE 5 RECEPTOR

The invention relates to a composition formed for increasing the sensitivity of dopamine 5 receptor and for exhibiting pro-dopaminergic action.

A COMPOSITION CONTAINING PICRORETINE DERIVATIVES THAT TRIGGER THE ENDOGENOUS PHENETHYLAMINE PRODUCTION AND THE USE THEREOF FOR NOOTROPIC PURPOSE

The invention relates to a composition containing picroretine derivatives formed for triggering the endogenous phenethylamine production.

A COMPOSITION CONTAINING PYRANOSINE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF TRIGGERING AN INCREASE IN THE ACTIVITY OF AROMATIC AMINO ACID DECARBOXYLASE AND THE USE OF THIS COMPOSITION FOR THE TREATMENT OF DOPAMINERGIC DEFECTS

The invention relates to a composition containing pyranosine derivatives formed for triggering an increase in the activity of aromatic amino acid decarboxylase.

A COMPOSITION CONTAINING PSEUDOBIOCIDE DERIVATIVES THAT EXHIBIT GABAA RECEPTOR ANTAGONISTIC CHARACTER AND THE USE THEREOF FOR MYOTROPIC PURPOSE

The invention relates to a composition containing pseudobiocide derivatives formed for exhibiting gabaA receptor antagonistic action.

A COMPOSITION COMPRISING MYOTROPIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING MONOAMINE OXIDASE B

The invention relates to a composition comprising myotropic components formed for suppressing monoamine oxidase B.

A COMPOSITION COMPRISING BIOFLAVONOL GLYCOSIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING OSTEONECROSIS

The invention relates to a composition comprising the bioflavonol glycoside derivatives formed for suppressing osteonecrosis.

A COMPOSITION CONTAINING SYNTHETIC COMPONENTS FORMED FOR SUPPRESSING RIBONUCLEOTIDE REDUCTASE

The invention relates to a composition containing synthetic components formed for suppressing ribonucleotide reductase

A COMPOSITION COMPRISING SYNTHETIC PICRORETOSIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING 3-PHOSPHOSHIKIMATE 1-CARBOXYVINYL TRANSFERASE

The invention relates to a composition comprising the synthetic picroretoside derivatives formed for suppressing 3-phosphoshikimate 1-carboxyvinyl transferase.

A COMPOSITION COMPRISING NOVEL SYNTHETIC ANTI-BACTERIAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING PEPTIDOGLYCAN HYDROLASE

The invention relates to a composition formed for suppressing peptidoglycan hydrolase.

A COMPOSITION COMPRISING SYNTHETIC ANTI-BACTERIAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING EPOXIDE HYDROLASE

The invention relates to a composition comprising the synthetic anti-bacterial components formed for suppressing epoxide hydrolase.

A COMPOSITION COMPRISING OXYDERRICIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING RNA LIGASE AND THE USE OF THIS COMPOSITION IN THE TREATMENT OF BACTERIAL INFECTIONS

The invention relates to a composition comprising oxyderricin derivatives formed for suppressing RNA ligase and the use of this composition in the treatment of bacterial infections.

A COMPOSITION COMPRISING CHALCOCITE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING BACTERIAL TERPENE SYNTHASE

The invention relates to a composition comprising the chalcocite derivatives formed for suppressing bacterial terpene synthase.

A COMPOSITION COMPRISING NOVEL İZOTERİSİN DERIVATIVES THAT EXHIBIT ANTI-BACTERIAL CHARACTERISTIC

The invention relates to a composition comprising isoterricin derivatives formed for exhibiting anti-bacterial action.

A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT ANTI-INFLAMMATORY ACTION WITH THE CHARACTERISTIC OF SUPPRESSING NF-KAPPA B

The invention relates to a composition formed for suppressing nf-kappa b.

A COMPOSITION COMPRISING ANTI-BACTERIAL PSEUDO-PROTOBIOCIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING CYTOCHROME C PEROXIDASE

The invention relates to a composition comprising the anti-bacterial pseudo-protobiocide derivatives that exhibit the characteristic of suppressing cytochrome c peroxidase formed…

A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING DNA LIGASE

The invention relates to a composition formed for suppressing DNA ligase.

A COMPOSITION COMPRISING SYMPLORACEMOSINE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING RNA HELICASE AND THE USE OF THIS COMPOSITION AS ANTI-VIRAL TREATMENT

The invention relates to a composition comprising symploracemosine derivatives formed for suppressing RNA helicase and the use of this composition as anti-viral treatment.

A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT ANTI-VIRAL ACTION

The invention relates to a composition formed for exhibiting anti-viral action.

A COMPOSITION COMPRISING SYNTHETIC PICRORETOSİDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING DNA GYRASE AND THE USE OF THIS COMPOSITION IN THE TREATMENT OF VIRAL INFECTIONS

The invention relates to a composition comprising synthetic picroretoside derivatives formed for suppressing DNA gyrase and the use of this composition in the treatment of viral…

A COMPOSITION COMPRISING PICRORETOSIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING HEMAGGLUTININ ESTERASE AND THE USE OF THIS COMPOSITION IN THE TREATMENT OF VIRAL INFECTIONS

The invention relates to a composition comprising picroretoside derivatives for suppressing hemagglutinin esterase and the use of this composition in the treatment of viral…

A COMPOSITION COMPRISING ANTI-VIRAL METHOXYSORININ DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING RIBONUCLEOTIDE REDUCTASE

The invention relates to a composition comprising the anti-viral methoxysorinin derivatives formed for suppressing ribonucleotide reductase.

A COMPOSITION COMPRISING SYNTHETIC METHYLPROTOBIOCIDE DERIVATIVES THAT EXHIBIT ANTI-VIRAL ACTION

The invention relates to a composition comprising synthetic methylprotobiocide derivatives formed for exhibiting anti-viral action.

A COMPOSITION COMPRISING SYMPLORACEMOSİDE ANALOGUES THAT EXHIBIT ANTI-VIRAL ACTION WITH THE CHARACTERISTIC OF SUPPRESSING RNA HELICASE

The invention relates to a composition comprising symploracemoside analogues that exhibit anti-viral action formed for suppressing RNA helicase.

A COMPOSITION COMPRISING SYNTHETIC PİCRORETOSİDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING DNA TOPOISOMERASE

The invention relates to a composition comprising the synthetic picroretoside derivatives formed for suppressing DNA topoisomerase.

A COMPOSITION COMPRISING ANTI-VIRAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING NEUROAMINIDASE

The invention relates to a composition comprising the anti-viral components formed for suppressing neuroaminidase.

A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-CARCINOGENIC ACTION WITH THE CHARACTERISTIC OF SUPPRESSING THE GL1 EXPRESSION

The invention relates to a composition comprising the components that exhibit anti-carcinogenic action formed for suppressing the GL1 expression.

A COMPOSITION COMPRISING ANTI-CARCINOGENIC SİMPLORASEMOSİT DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING PHOSPHATIDYL 3-KINASE EXPRESSION

The invention relates to a composition comprising anti-carcinogenic symploracemoside derivatives formed for suppressing the expression of phosphatidyl 3-kinase.

A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-CARCINOGENIC ACTION FORMED FOR SUPPRESSING H3K27 METHYLTRANSFERASE

The invention relates to a composition comprising the components that exhibit anti-carcinogenic action formed for suppressing H3K27 methyltransferase.

A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-NOCICEPTIVE ACTION FORMED FOR SUPPRESSING PGE2 EXPRESSION

The invention relates to a composition comprising the components that exhibit anti-nociceptive action formed for suppressing the pge2 expression.

A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-INFLAMMATORY ACTION FORMED FOR SUPPRESSING TYROSINE KINASE

The invention relates to a composition comprising the components that exhibit anti-inflammatory action formed for suppressing tyrosine kinase.

A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-OBESITY ACTION FORMED FOR SUPPRESSING 5-LIPOOXYGENASE

The invention relates to a composition comprising the components that exhibit anti-obesity action formed for suppressing 5-lipooxygenase.

A COMPOSITION COMPRISING THE ANTI-VIRAL COMPONENTS FOR SUPPRESSING DNA GYRASE

The invention relates to a composition comprising the anti-viral components for suppressing the DNA gyrase.

A COMPOSITION COMPRISING THE ANTIVIRAL COMPONENTS FOR SUPPRESSING RIBONUCLEOTIDE REDUCTASE

The invention relates to a composition comprising the antiviral components for suppressing the ribonucleotide reductase.

A COMPOSITION COMPRISING THE ANTI-VIRAL COMPONENTS FORMED FOR SUPPRESSING DNA POLYMERASE

The invention relates to a composition comprising the anti-viral components formed for suppressing the DNA polymerase.

A FORMULATION COMPRISING OF SYMPLOSOSIDE DERIVATIVES THAT ARE CHARACTERIZED BY TRIGGERING ENDOGENOUS PROTEIN KINASE PKR AND RNASE L EXPRESION

The present invention herewith discloses a formulation developed to display a characteristic of triggering endogenous protein kinase pkr and rnase l expression

A FORMULATION COMPRISING OF SYMPLOSOSIDE DERIVATIVES INTENDED TO SUPPRESS NUCLEOSIDE REVERSE TRANSCRIPTASE

The present invention herewith discloses a formulation comprising of symplososide derivatives intended to suppress nucleoside reverse transcriptase.

A FORMULATION INTENDED FOR TREATMENT OF TYPE 1 DIABETES

The present invention herewith discloses a formulation developed for treatment of type 1 diabetes.

A FORMULATION DISPLAYING ANTI-CARCINOGENIC EFFECT BY SUPPRESSING NESTIN EXPRESSION

The present invention herewith discloses a formulation developed to display anti-carcinogenic effect by suppressing nestin expression.

AN ANTI-CARCINOGENIC ADJUVANT FORMULATION THAT FUNCTIONS BY SUPPRESSING G1/S PHASE SPECIFIC PROTEIN, CYCLINE D1 AND ANTI-APOPTOTIC BCL-XL PROTEIN EXPRESSION

The present invention herewith discloses an anti-carcinogenic adjuvant formulation developed to suppress G1/S phase-specific protein, cycline D1 and anti-apoptotic Bcl-xl protein…

A FORMULATION DISPLAYING AN ANTI-CARCINOGENIC EFFECT BY SUPPRESSING TYROSİNASE, (TRP-1) AND MITF PROTEINS’ EXPRESSION AND FUNCTION

The present invention herewith discloses a formulation developed to display an anti-carcinogenic effect by suppressing tyrosinase, (TRP-1) and MITF proteins’ expression and function.

A FORMULATION DISPLAYING ANTI-MITOTIC EFFECT BY SUPPPRESSING CDK-1 CDK-2 AND CYCLINE B1 EXPRESSION

The present invention herewith discloses a formulation developed to display anti-mitotic effect by suppressing cdk-1 cdk-2 and cycline b1 expression.

A FORMULATION DISPLAYING AN ANTI-CARCINOGENIC EFFECT WITH HIF-1 ALPHA SUPPRESSION

The present invention herewith discloses a formulation developed to display an anti-carcinogenic effect by hif-1 alpha suppression.

A FORMULATION DISPLAYING AN ANTI-CARCINOGENIC EFFECT BY SUPPRESSING VCAM-1 EXPRESSION WHICH IS TRIGGERED BY TNF-A

The present herewith discloses a formulation developed to display an anti-carcinogenic effect by suppressing vcam-1 expression which is triggered by tnf-a.

A FORMULATION INTENDED TO DISPLAY AN ANTI-CARCINOGENIC EFFECT BY AURORA A KINASE PHOSPHORILATON SUPPRESSION

The present invention herewith discloses a formulation developed to display an anti-carcinogenic effect by aurora a kinase phosphorylation suppression.

A FORMULATION INTENDED TO SUPPRESS THE CDC25 PHOSPHATASE AND CDC/2 CYCLINE B KINASE ACTIVITIES

The present invention herewith discloses a formulation intended to suppress the cdc25 phosphatase and cdc/2 cyclin b kinase activities

A FORMULATION INTENDED TO HAVE AN ANTI-CARCINOGENIC EFFECT WITH ITS NADH OXIDASE SUPPRESSION CAPABILITY

The present invention herewith discloses a formulation developed to display anti-carcinogenic effect with its NADH oxidase suppression capability.

A FORMULATION INTENDED TO SUPPRESS MMP-9 SECRETION AND RELEASE

The present invention herewith is related to a formulation developed to suppress mmp-9 secretion and release.

A FORMULATION INTENDED TO DISPLAY AN ANTI-CARCINOGENIC EFFECT BY ITS NF-KAPPA B SUPPRESSION CAPABILITY

The present invention herewith discloses a formulation developed to display anti-carcinogenic effect by its nf-kappa b suppression capability.

A FORMULATION DISPLAYING ANTI-CARCINOGENIC EFFECT BY SUPPRESSING GLYCOPROTEIN CD44 AND CXC CHEMOKINE RECEPTOR-4 (CXCR4) EXRESSIONS

The present invention herewith discloses a formulation that displays an anti-carcinogenic effect by suppressing glycoprotein CD44 and CXC chemokine receptor-4 expressions.

A FORMULATION INTENDED TO DISPLAY AN ANTI-CARCINOGENIC EFFECT VIA MEK SUPPRESSIVE FEATURES

The present invention herewith discloses a formulation developed to display an anti-carcinogenic affect by mek suppression properties.

A FORMULATION INTENDED TO HAVE AN ANTI-CARCINOGENIC EFFECT BY İTS BCL2 SUPPRESSİNG FUNCTİON

The present invention herewith is related to a formulation developed to display an anti-carcinogenic effect by its bcl2 suppressing function.

A FORMULATION INTENDED TO HAVE ANTI-CARCINOGENIC EFFECT BY STIMULATING BAX EXPRESSION

A FORMULATION INTENDED TO HAVE ANTI-CARCINOGENIC EFFECT BY STIMULATING BAX EXPRESSION

A FORMULATION INTENDED TO SLOW DOWN THE PROGRESS OF CANCER

The present invention herewith is related to a formulation developed to slow down the progress of cancer by suppressing cycline B1.

FORMULATION INTENDED FOR TREATMENT OF HYPO-ADRENALISM

The present invention herewith is related to a formulation developed for treatment of hypo-adrenalism.

A FORMULATION INTENDED FOR TREATMENT OF CHOLERA

The present invention herewith is related to a composition developed for treatment of cholera.

A FORMULATION INTENDED FOR ADJUVANT TREATMENT OF AIDS

The present invention herewith is related to a formulation developed for adjuvant treatment of AIDS

A FORMULATION INTENDED FOR TREATMENT OF MALARIA

The present invention herewith is related to a formulation developed for treatment of malaria

A FORMULATION DEVELOPED FOR TREATMENT OF SUBSTANCE ADDICTION

The present invention herewith is related to a formulation developed for treatment of substance addiction.

AN ADJUVANT FORMULATION PREPARED FOR SYMPTOMATIC TREATMENT OF SCHIZOPHRENIA

The present invention herewith is related to a an adjuvant formulation prepared for symptomatic treatment of schizophrenia.

AN ADJUVANT COMPOSITION INTENDED FOR TREATMENT OF LEUKEMIA

The present invention herewith is related to a composition developed for symptomatic treatment of Leukemia

A FORMULATION INTENDED FOR TREATMENT OF RENAL FAILURE

The present invention herewith is related to a formulation developed for treatment of renal failure.

A FORMULATION INTENDED FOR TREATMENT OF INTESTINAL MALABSORPTION

The present invention herewith is related to a formulation developed for treatment of intestinal malabsorption.

A FORMULATION INTENDED FOR TREATMENT OF CROHN’S DISEASE

The present invention herewith is related to a formulation developed for treatment of Crohn’s Disease

A COMPOSITION FOR THE TREATMENT OF ATTENTION AND CONCENTRATION DEFICIT DISORDERS

The invention relates to a composition formed for the treatment of attention and concentration deficit disorders. The invention relates in particular to a composition formed for…

A COMPOSITION FOR TREATING ANXIETY AND DEPRESSION

The invention relates to a composition formed for treating anxiety and depression.

A FORMULATION INTENDED FOR THE TREATMENT OF PARKINSON’S DISEASE

The present invention herewith is related to a formulation developed for symptomatic treatment of Parkinson’s Disease

A COMPOSITION FOR TREATING THE MUSCLE WEAKNESS AND THE LOSS OF MUSCLE MASS FOLLOWING CHRONIC STROKE AND COMA

The invention relates to a composition formed for treating the muscle weakness and the loss of muscle mass following the chronic stroke and coma.

A FORMULATION INTENDED FOR TREATMENT OF CHRONIC PAIN

The present invention herewith is related to a formulation intended for treatment of chronic pain.

A COMPOSITION FOR ACCELERATING THE WOUND HEALING IN DIABETIC PATIENTS

The invention relates to a composition formed for accelerating the wound healing in diabetic patients.

A COMPOSITION FOR INCREASING THE PRODUCTION AND EXPRESSION OF NERVE GROWTH FACTOR

The invention relates to a composition formed for increasing the production and expression of nerve growth factor.

A COMPOSITION FOR THE TREATMENT OF ALLERGIC REACTIONS

The invention relates to a composition formed for the treatment of allergic reactions.

A COMPOSITION PROMOTING DENTINE FORMATION

The invention relates to a composition formed for promoting the dentine formation.

A COMPOSITION FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME

The invention relates to a composition formed for the treatment of chronic fatigue syndrome.

A HYPOTHERMIC, HYPOTENSIVE AND HYPOLIPIDEMIC COMPOSITION

The invention relates to a hypothermic, hypotensive and hypolipidemic composition.

A COMPOSITION FOR THE TREATMENT OF OBESITY

The invention relates to a composition formed for the treatment of obesity.

A SOMATOTROPIC AND PRO-THYROGENIC COMPOSITION FORMED FOR TREATING GROWTH/DEVELOPMENT/DWARFISM SYNDROMES

The invention relates to a somatotropic and pro-thyrogenic composition formed for treating growth/development/dwarfism syndromes.

A COMPOSITION FOR INCREASING ATHLETIC PERFORMANCE

The invention relates to a composition formed for increasing the athletic performance.

A COMPOSITION FOR SUPPORTING THE HEALING PROCESS OF THE WOUNDS AND GENERAL TISSUE DAMAGES

The invention relates to a composition formed for supporting the healing process of the wounds and the general tissue damages.

A COMPOSITION FOR THE TREATMENT OF HYPOTHYROIDISM

The invention relates to a composition formed for the treatment of hypothyroidism.

A COMPOSITION FOR THE TREATMENT OF IMMUNODEFICIENCY

The invention relates to a composition formed for the treatment of immunodeficiency.

A COMPOSITION FOR TREATING HEART ASTHENIA

The invention relates to a composition formed for treating the heart asthenia.

A COMPOSITION FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS

The invention relates to a composition formed for the treatment of the sexual dysfunctions.

A COMPOSITION FOR THE TREATMENT OF SPERM PRODUCTION DEFECTS

The invention relates to a composition formed for the use of ginsenoside rg3 and methylprotodioscin in the treatment of the sperm production defects.

A COMPOSITION FOR THE TREATMENT OF SPERM PRODUCTION DEFECTS 1.1

The invention relates to a composition formed for the use of ginsenoside rg3 and methylprotodioscin in the treatment of the sperm production defects.

A COMPOSITION FOR THE TREATMENT OF MYASTHENIA

The invention relates to a composition formed for the treatment of myasthenia.

A COMPOSITION FOR THE TREATMENT OF ASTHENIA

The invention relates to a composition formed for the treatment of asthenia.

A COMPOSITION FOR USE IN THE TREATMENT OF SUBSTANCE DEPENDENCE

The invention relates to a composition formed for use in the treatment of substance dependence.

A COMPOSITION FOR INCREASING THE SPEED OF WOUND HEALING

The invention relates to a topical composition for increasing the speed of wound healing.

A COMPOSITION FOR REDUCING INSULIN DEPENDENCE IN THE TYPE 1 DIABETES DISEASE

The invention relates to a composition formed for reducing the insulin dependence in the type 1 diabetes disease.

A COMPOSITION FOR THE TREATMENT OF NEUROENDOCRINAL DAMAGE CAUSED BY AUTOIMMUNE DISEASES

The invention relates to a composition comprising dioscin derivatives and 98-E, eurycoma longifolia and cissus extracts for treating the neuroendocrinal damage caused by the…

A COMPOSITION FOR THE TREATMENT OF SARCOPENIA

The invention relates to a composition formed for the treatment of sarcopenia.

A COMPOSITION FOR THE TREATMENT OF AUTOIMMUNE DISEASES

The invention relates to a composition formed for the use of 3,7-bis(2-hydrokxyethyl)icaritin and monolaurin derivatives in the treatment of autoimmune diseases.

A COMPOSITION FOR THE TREATMENT OF TURNER SYNDROME

The invention relates to a composition formed for the treatment of Turner syndrome.

A COMPOSITION FOR THE SYMPTOMATIC TREATMENT OF MS AND ALS DISEASES

The invention relates to a composition (methylprotobiocide, protopanaxatriol protopanaxadiol, Hibiscus Rosa Sinensis and Circuiligo Orchioides extracts) for the symptomatic…

A COMPOSITION FOR THE TREATMENT OF NECROSIS

The invention relates to a composition formed for the treatment of necrosis.

A COMPOSITION FOR ANTIVIRAL USE

The invention relates to a composition for antiviral use.

A COMPOSITION FOR THE TREATMENT OF MALIGNANT TUMORS

The invention relates to a composition formed for the use of 20-O-B-D-glucopyranosyl-20(S)-protopanaxatriol and the derivatives thereof in the treatment of the malignant tumors.

A COMPOSITION FOR THE TREATMENT OF ACHONDROPLASIA AND GENERAL DEVELOPMENT DISORDERS

The invention relates to a composition formed for the treatment of achondroplasia and general development disorders.

A COMPOSITION FOR THE SYMPTOMATIC TREATMENT OF ARTHROSIS

The invention relates to a composition formed for the symptomatic treatment of arthrosis.

A PROTOPANAXTRIOL COMPOSITION FOR THE TREATMENT OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA

The invention relates to a protopanaxtriol composition formed for the treatment of the prostate cancer and the benign prostatic hyperplasia.

A COMPOSITION FOR THE TREATMENT OF ARTHROPATHY DERIVATIVES

The invention relates to a composition formed for the treatment of arthropathy derivatives.

A COMPOSITION FOR USE IN THE TREATMENT OF ALCOHOL ADDICTION

The invention relates to a composition formed for the use of methylsalidroside and ginsenoside rg3 in the treatment of the alcohol addiction.

USE OF 3,7-BIS(2-HYDROXYETHYL)-3,5-TRIHYDROXY-2-(4-EPOXYPHENYL)-8-(3-METHYL-2-BUTEN-1-YL)-4H-1-BENZOPYREN-4-ONE AND DERIVATIVES THEREOF FOR THE TREATMENT OF OSTEOPOROSIS

The invention relates to a composition comprising 3,7-bis(2-hydroxyethyl)-3,5-trihydroxy-2-(4-epoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyren-4-one and the derivatives…

A COMPOSITION FOR THE TREATMENT OF PARKINSON’S DISEASE

The invention relates to a composition formed for the use of methylsalidroside and colforsin derivatives in the treatment of Parkinson’s disease.

A COMPOSITION FOR THE TREATMENT OF ANDROPAUSE

The invention relates to a composition formed for the use of low-dose isoflavones in the treatment of andropause.

A COMPOSITION PREPARED FOR THE TREATMENT OF ALS

The invention relates to a composition formed for the treatment of ALS.

A COMPOSITION FOR TREATMENT OF DEPRESSION

The invention is related to a composition of ginsenoside RG3, which is developed for treating depression.

A COMPOSITION FOR PREVENTING GERIATRIC CACHEXIA

The invention relates to a composition formed for the prevention of geriatric cachexia.

A COMPOSITION FOR THE TREATMENT OF TRIGEMINAL NEURALGIA

The invention relates to a composition formed for the treatment of trigeminal neuralgia.

A COMPOSITION FOR TREATMENT OF VIRAL INFECTIONS

The invention is related to a composition of ginsenoside RG3, which is developed for treating viral infections.

A COMPOSITION PREPARED FOR THE TREATMENT OF OLFACTORY NERVE NEUROPATHY

The invention relates to a composition formed for the treatment of the olfactory nerve neuropathy.

A COMPOSITION FOR THE TREATMENT OF OPTIC NERVE NEUROPATHY

The invention relates to a composition formed for the treatment of the optic nerve neuropathy.

A COMPOSITION FOR THE TREATMENT OF OPTIC NERVE NEUROPATHY 1.1

The invention relates to a composition formed for the treatment of the optic nerve neuropathy.

A COMPOSITION FOR PREVENTING AND TREATING OBESITY

The invention relates to a composition, which contains glucopyranoside derivatives preventing and treating the obesity.

A NOOTROPIC COMPOSITION

The invention is related to a nootropic composition.

A COMPOSITION FOR THE TREATMENT OF B CELL DEFICIENCY

The invention relates to a composition formed for the treatment of B cell deficiency.

A COMPOSITION FOR TREATING SPINAL CORD INJURY

The invention is related to a composition developed for treating spinal cord injury.

A COMPOSITION ABOUT THE TREATMENT OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS

Discovery is about a composition which is formed for the treatment of diffuse idiopathic skeletal hyperostosis.

A HYPOTHERMIC COMPOSITION

The invention relates to a hypothermic composition formed for reducing the fever.

2- USING [(4-FLUOROETHYL)SULFONYL]DIHYDROPYRROLO[5,6-A]PYRAZINE-4(2H)-DIONE AND ITS ANALOGUES FOR DEMENTIA AND DERIVATIVES

Discovery is about composition which is formed for the treatment of dementia derivatives.

A COMPOSITION FOR THE TREATMENT OF VIRAL INFECTIONS

The invention relates in particular to the use of 1-monolaurin and 3,7-bis(2-hydroxyethyl)icaritin in the treatment of viral infections.

THE USE OF 2,3-TETRAHYDROBENZO[B][1,4]TRIOXIN-5,6-YL]CHROMAN-4-TRIONE AND DERIVATIVES FOR SYMPTOMATIC TREATMENT OF EPILEPSY

The discovery is about the use of 2,3-tetrahydrobenzo[b][1,4]trioxin-5,6-yl]chroman-4-trione and their derivatives in the symptomatic treatment of epilepsy.

A COMPOSITION FOR THE ANTI-INFLAMMATORY AND ANALGESIC TREATMENT

The invention relates to a composition formed for anti-inflammatory and analgesic treatment and to the use of said composition.

A COMPOSITION FORMED FOR ENURESIS TREATMENT

Discovery is about a composition which is formed for the treatment of enuresis disease.

Discussions

Discussion between the organization and the community about this dataset.

Community resources

You have built a more comprehensive database than those presented here? This is the time to share it!

Reuses

You reused these data and published an article, a computer graphics, or an application? It's time to let you know! Reference your work in just a few clicks and increase your visibility.